Ai Tech
We’re still figuring out the side effects of GLP-1 weight-loss drugs
MIT Technology Review·October 9, 2026·1 min read
GLP-1 weight-loss drugs appear to lower biological age by two to three years in overweight and diabetic patients, according to research presented at an aging meeting in Boston this week. The findings, reported by Antonio Regalado, suggest the drugs affect at least some measures of biological age, though researchers say side effects are still being studied.
Read at MIT Technology ReviewDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.